Belarus plans to create joint venture in Azerbaijan to produce veterinary drugs

BelVitunipharm OJSC, based in Vitebsk oblast of Belarus, is creating a joint venture in Azerbaijan to produce veterinary drugs, the company's Director Ilya Darovskikh said, Report informs via Vitbichi.

"The production of veterinary drugs is being organized on the basis of the Azerbaijan Food Safety Institute. Vitebsk specialists, together with colleagues from Azerbaijan, will establish the production of an anti-rabies inactivated vaccine and a vaccine-containing bait against rabies," Darovskikh said.

According to the director, as a contribution to the joint venture, the Vitebsk manufacturer will provide technologies and assist [Azerbaijani] partners in equipping them with tools, primarily of Belarusian manufacture.

"The implementation of the project became possible due to the high level of political interaction between Belarus and Azerbaijan, the reliable foundation of which is the relationship between the leaders of the two countries," Darovskikh said.

According to him, the localization of vaccine production in the Azerbaijani market will make highly effective drugs more accessible to local consumers and contribute to the development of the veterinary healthcare system in Azerbaijan.

"In addition, BelVitunipharm has established supplies of chemical and pharmaceutical products to Azerbaijan. In the future, the company is working on the possibility of entering the neighboring market of Türkiye," he said.

He also noted that BelVitunipharm supplies products to the markets of about ten countries. The main export destinations include Russia and Kazakhstan, as well as Georgia.